Patient-Focused Medical Product Development Webinar Series

There is growing interest in clinical outcome assessments, such as patient-reported outcomes, and patient-centeredness across the health care ecosystem. For example, in 2019, the Food and Drug Administration released two new guidance documents on clinical outcome assessment. The NHC seeks to ensure that the NHC membership is prepared to engage in conversations about clinical outcome assessment. 

If you would like to suggest a topic, please submit one below.

Sponsors include: Amgen, Alkermes, Boehringer-Ingelheim, Eli Lilly, Johnson & Johnson, Merck, Pfizer, Sanofi